Estradiol increases rat aorta endothelium-derived relaxing factor (EDRF) activity without changes in endothelial NO synthase gene expression: possible role of decreased endothelium-derived superoxide anion production
Ma. Barbacanne et al., Estradiol increases rat aorta endothelium-derived relaxing factor (EDRF) activity without changes in endothelial NO synthase gene expression: possible role of decreased endothelium-derived superoxide anion production, CARDIO RES, 41(3), 1999, pp. 672-681
Citations number
57
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Objectives: Estradiol is known to exert a protective effect against atheros
clerosis, but the mechanism(s) whereby this protection is mediated is/are u
nclear. However, estradiol-treated castrated animals exhibit increased acti
vity of endothelium-derived relaxing factor (EDRF), which could contribute
to vasculoprotection. In the present work, we investigated the molecular me
chanism(s) of the enhancement of EDRF activity in the thoracic aorta of oop
horectomized female rats given 17 beta-estradiol (E-2, 2 or 40 mu g/kg/day)
compared to those given a placebo. Methods and Results: The abundance in t
he thoracic aorta of NO synthase I, II and III mRNA (using RT-PCR) and of N
O synthase I, II and III immunoreactive protein (using Western blotting) wa
s unaltered by E-2. NO synthase activity (based on arginine/citrulline conv
ersion) in thoracic aorta homogenates did not differ significantly among th
e three groups, suggesting that NO production was not enhanced by E-2. In c
ontrast, lucigenin-enhanced chemiluminescence of aorta from the E-2 group w
as decreased compared to that of the placebo group. Desendothelialization a
nd exogenously added superoxide dismutase suggested that this difference wa
s due to a decrease in extracellular endothelium-derived production of supe
roxide anion (O-2(-.)). Experiments in cultured bovine aortic endathelial c
ells confirmed a decreased extracellular production of O-2(-.) In response
to ethinylestradiol (1 nM) using both lucigenin-enhanced chemiluminescence
and ESR spectroscopy. Luminol-enhanced chemiluminescence revealed that ethi
nylestradiol-treated cultured endothelial cells generated less peroxynitrit
e (the byproduct of NO. and O-2(-.) interaction) than control cells. Conclu
sion: Estradiol increases rat aorta EDRF activity in the absence of changes
in endothelial NO synthase gene expression. The decreased endothelium-deri
ved generation of O-2(-.) in response to estrogens could account for enhanc
ed EDRF-NO bioactivity and decreased peroxynitrite release. All of these ef
fects could contribute to the vascular protective properties of estrogens.
(C) 1999 Published by Elsevier Science B.V. All rights reserved.